Variant report
Variant | nsv525840 |
---|---|
Chromosome Location | chr3:20643480-20644662 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6766464 | chr3:20643480-20643481 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
2 | rs143621709 | chr3:20643489-20643490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557879899 | chr3:20643491-20643492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573293177 | chr3:20643496-20643497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115196173 | chr3:20643501-20643502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562129817 | chr3:20643509-20643510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548633280 | chr3:20643561-20643562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9846771 | chr3:20643574-20643575 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs9827006 | chr3:20643591-20643592 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs148081340 | chr3:20643610-20643611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557591351 | chr3:20643625-20643626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185502996 | chr3:20643663-20643664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190426934 | chr3:20643673-20643674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143856501 | chr3:20643680-20643681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191245559 | chr3:20643709-20643710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35509686 | chr3:20643755-20643756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183802832 | chr3:20643762-20643763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9864698 | chr3:20643879-20643880 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs535065357 | chr3:20643996-20643997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188469756 | chr3:20644013-20644014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568811010 | chr3:20644047-20644048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539303227 | chr3:20644056-20644057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557944343 | chr3:20644069-20644070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556465763 | chr3:20644073-20644074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4858234 | chr3:20644092-20644093 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs534325395 | chr3:20644095-20644096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs11714456 | chr3:20644103-20644104 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs574013535 | chr3:20644112-20644113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181314398 | chr3:20644124-20644125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562047506 | chr3:20644133-20644134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562823714 | chr3:20644237-20644238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376300423 | chr3:20644244-20644245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11710467 | chr3:20644276-20644277 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs545681209 | chr3:20644281-20644282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560757176 | chr3:20644298-20644299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527857205 | chr3:20644366-20644367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554234393 | chr3:20644369-20644370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184843859 | chr3:20644377-20644378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147263717 | chr3:20644401-20644402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574698654 | chr3:20644537-20644538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550167886 | chr3:20644549-20644550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568476533 | chr3:20644560-20644561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs539364604 | chr3:20644580-20644581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:20639800-20644400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr3:20644400-20644600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |